BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hadizadeh DR, Jost G, Pietsch H, Weibrecht M, Perkuhn M, Boschewitz JM, Keil VC, Träber F, Kukuk GM, Schild HH, Willinek WA. Intraindividual quantitative and qualitative comparison of gadopentetate dimeglumine and gadobutrol in time-resolved contrast-enhanced 4-dimensional magnetic resonance angiography in minipigs. Invest Radiol 2014;49:457-64. [PMID: 24598442 DOI: 10.1097/RLI.0000000000000036] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Wilson GJ, Springer CS Jr, Bastawrous S, Maki JH. Human whole blood 1 H2 O transverse relaxation with gadolinium-based contrast reagents: Magnetic susceptibility and transmembrane water exchange. Magn Reson Med 2017;77:2015-27. [PMID: 27297589 DOI: 10.1002/mrm.26284] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
2 Szomolanyi P, Frenzel T, Noebauer-Huhmann IM, Rohrer M, Trattnig S, Pietsch H, Endrikat J. Impact of concentration and dilution of three macrocyclic gadolinium-based contrast agents on MRI signal intensity at 1.5T and 3T and different pulse sequences: results of a phantom study in human plasma. Acta Radiol 2021;62:51-7. [PMID: 32290676 DOI: 10.1177/0284185120915674] [Reference Citation Analysis]
3 Tsuboyama T, Jost G, Pietsch H, Tomiyama N. Comparison of Power Versus Manual Injection in Bolus Shape and Image Quality on Contrast-Enhanced Magnetic Resonance Angiography: An Experimental Study in a Swine Model. Invest Radiol 2017;52:547-53. [PMID: 28448310 DOI: 10.1097/RLI.0000000000000383] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
4 Budjan J, Attenberger UI, Schoenberg SO, Pietsch H, Jost G. The impact of injector-based contrast agent administration in time-resolved MRA. Eur Radiol 2018;28:2246-53. [PMID: 29218620 DOI: 10.1007/s00330-017-5178-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
5 Cerne JW, Pathrose A, Singer AM, Moore JE, Serhal A, Aouad P, Umair M, Ragin A, Allen BD, Avery R, Markl M, Carr JC. MRA of the Supraaortic Vasculature: Comparison of Gadobutrol and Gadoterate Meglumine at 1.5 T. J Magn Reson Imaging 2021. [PMID: 34953154 DOI: 10.1002/jmri.28044] [Reference Citation Analysis]
6 Glutig K, Bhargava R, Hahn G, Hirsch W, Kunze C, Mentzel HJ, Schaefer JF, Willinek W, Palkowitsch P; GARDIAN study group. Safety of gadobutrol in more than 1,000 pediatric patients: subanalysis of the GARDIAN study, a global multicenter prospective non-interventional study. Pediatr Radiol 2016;46:1317-23. [PMID: 27041276 DOI: 10.1007/s00247-016-3599-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
7 Jost G, Endrikat J, Pietsch H. The Impact of Injector-Based Contrast Agent Administration on Bolus Shape and Magnetic Resonance Angiography Image Quality. Magn Reson Insights 2017;10:1178623X17705894. [PMID: 28579796 DOI: 10.1177/1178623X17705894] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Liu X, Zhang W, Li Z, Fu Y, Ren J, Shen W, Wang J, Xu Y, Song B. Improved display of abdominal contrast-enhanced MRA using gadobutrol: comparison with Gd-DTPA. Clin Radiol 2019;74:978.e1-7. [PMID: 31551147 DOI: 10.1016/j.crad.2019.08.012] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Wu G, Jin T, Li T, Morelli J, Li X. High spatial resolution time-resolved magnetic resonance angiography of lower extremity tumors at 3T: Comparison with computed tomography angiography. Medicine (Baltimore) 2016;95:e4894. [PMID: 27631262 DOI: 10.1097/MD.0000000000004894] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]